VRTX

VRTX Long-Term Debt

$1.98BQuarterly · USD

Period ending:

VRTX FY Long-Term DebtUSD
VRTX FY Long-Term Debt1990-12-31: $2.40M1991-12-31: $2.10M1992-12-31: $3.30M1993-12-31: $4.20M1994-12-31: $4.70M1995-12-31: $4.90M1996-12-31: $5.60M1997-12-31: $5.90M1998-12-31: $7.00M1999-12-31: $4.69M2000-12-31: $357.27M2001-12-31: $323.03M2002-12-31: $325.94M2003-12-31: $359.19M2004-12-31: $335.00M2005-12-31: $0.002006-12-31: $20.00M2007-12-31: $0.002008-12-31: $287.50M2009-12-31: $121.77M2010-12-31: $400.00M2011-12-31: $455.95M2012-12-31: $683.20M2013-12-31: $489.69M2014-12-31: $792.94M2015-12-31: $739.40M2016-12-31: $521.34M2017-12-31: $583.90M2018-12-31: $581.55M2019-12-31: $622.87M2020-12-31: $889.50M2021-12-31: $887.20M2022-12-31: $810.30M2023-12-31: $724.70M2024-12-31: $1.66B2025-12-31: $3.80B$3.80B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX long-term debt history

Debt obligations due beyond one year. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Long-Term Debt — Annual fiscal periods (USD)
Period endingLong-Term Debt (USD)
3,799,700,000
1,657,200,000
724,700,000
810,300,000
887,200,000
889,500,000
622,868,000
581,550,000
583,902,000
521,335,000
739,397,000
792,935,000
489,691,000
683,201,000
455,950,000
400,000,000
121,765,000
287,500,000
0
19,997,000
0
334,997,000
359,188,000
325,944,000
323,026,000
357,269,000
4,693,000
7,000,000
5,900,000
5,600,000
4,900,000
4,700,000
4,200,000
3,300,000
2,100,000
2,400,000

Compare long-term debt

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.